Women Who Undergo Mastectomy and Reconstructive Surgery May Be at Risk of Becoming Persistent Drug Users
SAN ANTONIO – Women who receive mastectomy and reconstructive surgery as part of breast cancer treatment may face the...
Search/Filter
Loading...
Postmenopausal Women With Early-stage Breast Cancer and Low Recurrence Score Could Skip Adjuvant Chemotherapy
Adjuvant chemotherapy may yield improved survival outcomes for premenopausal counterparts SAN ANTONIO – After a median follow-up of 5.1...
Omitting Radiation Therapy After Breast-Conserving Surgery May Not Impact 10-year Survival Rates for Older Patients With HR-positive Breast Cancer
SAN ANTONIO – Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery...
Breast Cancer Survivors Are Less Likely to Get Pregnant, but Often Have Healthy Babies and Good Long-term Health
SAN ANTONIO – A large meta-analysis of breast cancer survivors of childbearing age indicated that they are less likely...
Updated monarchE Trial Data Shows Abemaciclib Continues to Benefit Patients With High-risk, HR-positive, HER2-negative, Early-stage Breast Cancer
SAN ANTONIO – Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK)...
Mary-Claire King, PhD, FAACR, Honored With 2020 William L. McGuire Memorial Lecture Award
SAN ANTONIO – Mary-Claire King, PhD, FAACR, will receive the William L. McGuire Memorial Lecture Award at the 2020...
Cancer Discovery to Publish COVID-19 and Cancer Consortium Data on Final Day of AACR COVID-19 and Cancer Meeting
PHILADELPHIA – Cancer Discovery, a journal of the American Association for Cancer Research, will publish a COVID-19 and Cancer...
Use of Lipophilic Statins is Associated with Lower Mortality from Ovarian Cancer
PHILADELPHIA – Lipophilic statins, a type of medication commonly prescribed to lower blood cholesterol, were associated with reduced mortality...
Young Adults With Cancer May Harbor Germline Mutations
Young cancer patients may benefit from germline genetic testing PHILADELPHIA – Young patients ages 18–39 with early-onset cancer were...
Real-world Data Shows Immunotherapy After Melanoma Surgery Yields Survival Benefit
Sociodemographic factors may play a role in receiving immunotherapy PHILADELPHIA – Data derived from a large real-world database showed...